CRNT(CRNT)
CRNT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $369M | $393M | $429M |
| Low | $367M | $386M | $422M |
| High | $372M | $400M | $433M |
| EBITDA Avg | $36M | $47M | $51M |
| Low | $34M | $41M | $51M |
| High | $36M | $48M | $52M |
| EBIT Avg | $21M | $32M | $36M |
| Low | $19M | $26M | $35M |
| High | $22M | $33M | $36M |
| Net Income Avg | $10M | $17M | $20M |
| Low | $8M | $13M | $19M |
| High | $10M | $18M | $20M |
| EPS Avg | $0.10 | $0.18 | $0.22 |
| Low | $0.09 | $0.15 | $0.22 |
| High | $0.11 | $0.20 | $0.22 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $94M | $96M | $95M | $99M | $100M | $103M |
| Low | $92M | $93M | $93M | $97M | $98M | $101M |
| High | $96M | $99M | $96M | $100M | $102M | $105M |
| EBITDA Avg | $10M | $11M | $10M | $12M | $14M | $14M |
| Low | $9M | $10M | $10M | $12M | $14M | $14M |
| High | $11M | $13M | $10M | $12M | $14M | $14M |
| EBIT Avg | $7M | $8M | $6M | $8M | $10M | $10M |
| Low | $6M | $6M | $6M | $8M | $10M | $10M |
| High | $7M | $9M | $6M | $8M | $10M | $10M |
| Net Income Avg | $3M | $4M | $3M | $4M | $5M | $5M |
| Low | $2M | $3M | $3M | $4M | $5M | $5M |
| High | $3M | $5M | $3M | $4M | $6M | $6M |
| EPS Avg | $0.04 | $0.04 | $0.03 | $0.04 | $0.06 | $0.06 |
| Low | $0.03 | $0.03 | $0.03 | $0.04 | $0.06 | $0.06 |
| High | $0.04 | $0.05 | $0.03 | $0.05 | $0.06 | $0.06 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |